Back to MORGAN STANLEY MORGAN STANLEY

ADAPYADAPY
7 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs

MORGAN STANLEY previously held 0 shares of ADAPY (ADAPTIMMUNE THERAPEUTICS PLC Spon ADS Each Rep 6 Ord Shs), worth $0 as of 2025-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$429,768

Total Shares Change

-440,832

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$0.03
0
2025-Q3
Decreased
3.7M
-13.4%
$476,5880.0%$0.14
0
2025-Q2
Increased
4.2M
+55.8%
$1M0.0%$0.25
35
2025-Q1
Increased
2.7M
+105.0%
$535,0410.0%$0.21
27
2024-Q4
Decreased
1.3M
-22.0%
$713,7050.0%$0.55
0
2024-Q3
Increased
1.7M
+285.4%
$1.6M0.0%$0.98
41
2024-Q2
New
440,832
-
$429,7680.0%$0.98
37

Other major holders of ADAPY: RA CAPITAL MANAGEMENT, L.P., Avoro Capital Advisors LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used